499 related articles for article (PubMed ID: 25219538)
1. Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents.
Gibson JK; Yue Y; Bronson J; Palmer C; Numann R
J Pharmacol Toxicol Methods; 2014; 70(3):255-67. PubMed ID: 25219538
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Possible Proarrhythmic Potency: Comparison of the Effect of Dofetilide, Cisapride, Sotalol, Terfenadine, and Verapamil on hERG and Native IKr Currents and on Cardiac Action Potential.
Orvos P; Kohajda Z; Szlovák J; Gazdag P; Árpádffy-Lovas T; Tóth D; Geramipour A; Tálosi L; Jost N; Varró A; Virág L
Toxicol Sci; 2019 Apr; 168(2):365-380. PubMed ID: 30561737
[TBL] [Abstract][Full Text] [Related]
3. Recording of multiple ion current components and action potentials in human induced pluripotent stem cell-derived cardiomyocytes via automated patch-clamp.
Mann SA; Heide J; Knott T; Airini R; Epureanu FB; Deftu AF; Deftu AT; Radu BM; Amuzescu B
J Pharmacol Toxicol Methods; 2019; 100():106599. PubMed ID: 31228558
[TBL] [Abstract][Full Text] [Related]
4. CSAHi study: Detection of drug-induced ion channel/receptor responses, QT prolongation, and arrhythmia using multi-electrode arrays in combination with human induced pluripotent stem cell-derived cardiomyocytes.
Kitaguchi T; Moriyama Y; Taniguchi T; Maeda S; Ando H; Uda T; Otabe K; Oguchi M; Shimizu S; Saito H; Toratani A; Asayama M; Yamamoto W; Matsumoto E; Saji D; Ohnaka H; Miyamoto N
J Pharmacol Toxicol Methods; 2017; 85():73-81. PubMed ID: 28163191
[TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (I(Kr)) channel.
Davie C; Pierre-Valentin J; Pollard C; Standen N; Mitcheson J; Alexander P; Thong B
J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1302-9. PubMed ID: 15574182
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Drug Proarrhythmic Potential in Electrically Paced Human Induced Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes Using Multielectrode Array.
Bai S; Pei J; Chen K; Zhao Y; Cao H; Tian L; Ma Y; Dong H
SLAS Discov; 2021 Mar; 26(3):364-372. PubMed ID: 32914673
[TBL] [Abstract][Full Text] [Related]
7. Comparison of guinea-pig ventricular myocytes and dog Purkinje fibres for in vitro assessment of drug-induced delayed repolarization.
Terrar DA; Wilson CM; Graham SG; Bryant SM; Heath BM
J Pharmacol Toxicol Methods; 2007; 56(2):171-85. PubMed ID: 17596973
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes.
Lee S; Lee HA; Choi SW; Kim SJ; Kim KS
Toxicol Appl Pharmacol; 2016 Apr; 296():42-53. PubMed ID: 26821276
[TBL] [Abstract][Full Text] [Related]
9. Human embryonic stem cell derived cardiac myocytes detect hERG-mediated repolarization effects, but not Nav1.5 induced depolarization delay.
Qu Y; Gao B; Fang M; Vargas HM
J Pharmacol Toxicol Methods; 2013; 68(1):74-81. PubMed ID: 23518063
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological enhancement of repolarization reserve in human induced pluripotent stem cells derived cardiomyocytes.
Treat JA; Goodrow RJ; Bot CT; Haedo RJ; Cordeiro JM
Biochem Pharmacol; 2019 Nov; 169():113608. PubMed ID: 31465775
[TBL] [Abstract][Full Text] [Related]
11. Specific prediction of clinical QT prolongation by kinetic image cytometry in human stem cell derived cardiomyocytes.
Pfeiffer ER; Vega R; McDonough PM; Price JH; Whittaker R
J Pharmacol Toxicol Methods; 2016; 81():263-73. PubMed ID: 27095424
[TBL] [Abstract][Full Text] [Related]
12. The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes.
Peng S; Lacerda AE; Kirsch GE; Brown AM; Bruening-Wright A
J Pharmacol Toxicol Methods; 2010; 61(3):277-86. PubMed ID: 20153443
[TBL] [Abstract][Full Text] [Related]
13. Proarrhythmic risk assessment using conventional and new in vitro assays.
Goineau S; Castagné V
Regul Toxicol Pharmacol; 2017 Aug; 88():1-11. PubMed ID: 28506844
[TBL] [Abstract][Full Text] [Related]
14. The Use of Ratiometric Fluorescence Measurements of the Voltage Sensitive Dye Di-4-ANEPPS to Examine Action Potential Characteristics and Drug Effects on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Hortigon-Vinagre MP; Zamora V; Burton FL; Green J; Gintant GA; Smith GL
Toxicol Sci; 2016 Dec; 154(2):320-331. PubMed ID: 27621282
[TBL] [Abstract][Full Text] [Related]
15. Improvement of acquisition and analysis methods in multi-electrode array experiments with iPS cell-derived cardiomyocytes.
Asakura K; Hayashi S; Ojima A; Taniguchi T; Miyamoto N; Nakamori C; Nagasawa C; Kitamura T; Osada T; Honda Y; Kasai C; Ando H; Kanda Y; Sekino Y; Sawada K
J Pharmacol Toxicol Methods; 2015; 75():17-26. PubMed ID: 25910965
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of KCNJ2 in induced pluripotent stem cell-derived cardiomyocytes for the assessment of QT-prolonging drugs.
Li M; Kanda Y; Ashihara T; Sasano T; Nakai Y; Kodama M; Hayashi E; Sekino Y; Furukawa T; Kurokawa J
J Pharmacol Sci; 2017 Jun; 134(2):75-85. PubMed ID: 28615142
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological characteristics and pharmacological sensitivity of two lines of human induced pluripotent stem cell derived cardiomyocytes coming from two different suppliers.
Goineau S; Castagné V
J Pharmacol Toxicol Methods; 2018; 90():58-66. PubMed ID: 29274391
[TBL] [Abstract][Full Text] [Related]
18. Activation of the unfolded protein response downregulates cardiac ion channels in human induced pluripotent stem cell-derived cardiomyocytes.
Liu M; Shi G; Zhou A; Rupert CE; Coulombe KLK; Dudley SC
J Mol Cell Cardiol; 2018 Apr; 117():62-71. PubMed ID: 29474817
[TBL] [Abstract][Full Text] [Related]
19. Action potential characterization of human induced pluripotent stem cell-derived cardiomyocytes using automated patch-clamp technology.
Scheel O; Frech S; Amuzescu B; Eisfeld J; Lin KH; Knott T
Assay Drug Dev Technol; 2014 Oct; 12(8):457-69. PubMed ID: 25353059
[TBL] [Abstract][Full Text] [Related]
20. Functional Impact of BeKm-1, a High-Affinity hERG Blocker, on Cardiomyocytes Derived from Human-Induced Pluripotent Stem Cells.
De Waard S; Montnach J; Ribeiro B; Nicolas S; Forest V; Charpentier F; Mangoni ME; Gaborit N; Ronjat M; Loussouarn G; Lemarchand P; De Waard M
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
